(NYSE: PFE) today announced that updated clinical trial data for vepdegestrant (ARV-471) will be presented at the 2023 San Antonio Breast Cancer ...
News
- Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at ...
- bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, ...
- After a mastectomy, many women can't afford breast reconstruction. This nonprofit wants to help.
Bioscience-Medicine ... This nonprofit wants to help. Ice on plants in Boerne on Feb. 1, 2023. Environment · San Antonio's first freeze of the season ...
- bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
SAN ANTONIO, November 28, 2023--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need ...
- Bharat Biotech forge strategic partnership with University of Sydney for vaccine research
Bharat Biotech International Limited and the University of Sydney ... San Antonio News · San Diego News · San Francisco News · San Jose News · Santa ...